More Business Wire
View Older Stories View Newer Stories-
Smart & Final Extra! Store to Open Wednesday, April 24 in Temecula
-
Club Wyndham Gifts Moms the Ultimate Breakfast-In-Bed Experience This Mother’s Day
-
IndexIQ Announces Change to ETF Lineup
-
Terreno Realty Corporation Sells Property in Seattle, WA for $11.0 Million
-
Acrisure Rolls Out Midwest Region Serving America’s Heartland
-
Calix to Post First Quarter 2024 Results on April 22, 2024
-
Sinclair Broadcast Group Names Shuneca Harrington Vice President and General Manager of WRLH/FOX in Richmond, VA
-
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
-
MP Materials Awarded $58.5 Million to Advance U.S. Rare Earth Magnet Manufacturing
-
Upland Software Secures Another 40+ Badges in G2’s Spring 2024 Market Reports
-
Oragenics, Inc. Files 10K and Provides Company Update
-
Astound Broadband Launches Partnership with Habitat for Humanity to Support Creating Equitable, Inclusive Communities Across the U.S.
-
Bayer Appoints Sue Ann Pentecost as Vice President, Head of U.S. Pharmaceutical Communications
-
The Standard Closes Acquisition of Life & Disability Business from Elevance Health, Enters Distribution Partnership
-
American Financial Group, Inc. Declares Quarterly Dividend
-
Optimum to Bring 100% Fiber Internet Network to Montclair and West Orange, New Jersey
-
Lomiko Announces Excellent Results From the La Loutre Graphite Single-Layer Phase 2 Pouch Cell Battery Testing and Suitability as Battery Anode Material and Company Update on Bourier
-
GPCR Therapeutics Announces Publication in PNAS Using Cutting Edge Spectroscopy to Detect GPCR Heteromers on Live Cancer Cells
-
ICE Mortgage Monitor: Trading Up to a 25% More Expensive Home Would More Than Double the Average Mortgage Holder’s Payment
-
HKW Strengthens Investment Team Across Core Competencies with Two New Partners
-
Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024
-
Dave & Buster’s International Growth Momentum Continues
-
Study Finds C₂N Diagnostics’ PrecivityAD® Blood Test Provides Opportunities for Robust Cost Savings in the Evaluation of Patients with Cognitive Impairment
-
Cyara Named Winner in Best of Enterprise Connect Awards
-
FIGS Releases Its 2023 Impact Report
-
Schneider National, Inc. to report First Quarter 2024 Earnings on May 2, 2024
-
Texan by Nature Announces 2024 Conservation Wranglers
-
SafeSport Implementing Improvements to Increase Efficiency and Information Sharing
-
Pioneer Closed-End Fund Required Notice to Shareholders Sources of Distribution Under Section 19(a)
-
Homrich Berg Welcomes Michael A. Woocher as New Chief Advisory Officer and Principal
-
WILLIAMS SONOMA AND WILLIAMS SONOMA HOME INTRODUCE NEW COLLECTIONS WITH GLOBAL LUXURY LIFESTYLE BRAND AERIN
-
Sam's Club Business Membership Guide (2024) Published by Better Business Advice
-
Guaranty Bancshares, Inc. Announces First Quarter 2024 Earnings Release and Conference Call Schedule
-
NEPC Hires Former PGIM Principal To Lead DC Solutions
-
Earnix Appoints Craig Campestre as Chief Revenue Officer to Drive Strategic Growth
-
LIB Therapeutics Announces Abstracts Accepted for Presentation at the American College of Cardiology Scientific Session 2024
-
Cushman & Wakefield Recognized by Fitwel for 2024 “Best in Building Health” Awards
-
Centivo Announces Ryan Moore as Chief Revenue Officer
-
Reinsurance Group of America Appoints New Member to Board of Directors
-
Understand the Risk of Pests and Proper Prevention Measures this National Pest Management Month
-
Regions Financial Announces John Jordan to Serve as Head of Retail
-
Pembina Pipeline Corporation Announces Closing of Acquisition of Enbridge’s Interest in Alliance/Aux Sable and Raises 2024 Guidance
-
Business Park Sofia Celebrates Wave of New and Renewed Leases
-
BRW Announces $0.085 Dividend
-
SABA Announces $0.029 Dividend
-
Central Valley Community Bancorp Completes Community West Bancshares Merger, Adopts Name, Announces Board and Executive Reorganization
-
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
-
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
-
Guerrilla RF Announces Completion of $5.0 Million Private Placement Equity Financing and Related Transactions
-
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Ente
